Co-Diagnostics Inc.
CODX | NASDAQ
$1.01
+$0.06 (+6.80%)
At close: Sep 21, 2026, 4:00 PM ET
$1.04
+$0.03 (+2.97%)
Pre-market:
Sep 22, 2026, 5:40 AM ET
Market Data
Market Cap $1.06M
Enterprise Value $-723.08K
Beta 2.86
Average Volume 4.12M
Shares Outstanding (Diluted) 4.31M
Shares Change YoY 290.54%
Institutional Ownership 2.18%
Exchange NASDAQ
ISIN US1897632048
Price Performance
Price Change 1M -20.5%
Price Change 3M -68.7%
Price Change 6M -48.7%
Price Change YTD -81.8%
Price Change 1Y -92.0%
Price Change 3Y -96.8%
Price Change 5Y -99.7%
1M CAGR (ann.) -33.4%
1Y CAGR (ann.) -92.4%
5Y CAGR (ann.) -68.8%
All-Time CAGR -43.3%
Valuation
PE Ratio -0.04
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio 1.56
Forward PS 0.10
PB Ratio 0.09
P/FCF Ratio -0.04
P/Adj. FCF Ratio -0.04
P/OCF Ratio -0.16
EV/Sales -1.00
EV/EBIT 0.02
EV/EBITDA 0.02
EV/FCF 0.03
Earnings Yield -2645.5%
FCF Yield -2436.6%
Adj. FCF Yield -2545.3%
Financial Health
Net Cash $1.85M
Total Debt $1.8M
Cash & Short-Term Investments $3.65M
Total Assets $16.59M
Current Ratio 1.81
Quick Ratio 1.52
Debt / Equity Ratio 0.14
Debt / EBITDA -0.04
Debt / FCF -0.07
OCF / Debt -15.06
Interest Coverage 0.00
Altman Z-Score -15.68
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 8.1%
Operating Profit Margin -4170.1%
EBITDA Margin -6590.0%
Net Profit Margin -6523.0%
FCF Margin -3808.0%
Adj. FCF Margin -3977.9%
SBC / Revenue 169.9%
SBC Impact (per share) -4.5%
Returns
Return on Assets -283.6%
Return on Equity -211.0%
Return on Invested Capital -200.4%
Return on Capital Employed -219.2%
Return on Tangible Assets -502.1%
Historical Growth (CAGR)
Revenue CAGR 3Y -53.8%
Revenue CAGR 5Y -62.4%
Revenue CAGR 10Y 43.1%
EPS CAGR 3Y 16.0%
EPS CAGR 5Y -47.3%
EPS CAGR 10Y -36.7%
FCF CAGR 3Y -3.5%
FCF CAGR 5Y -79.0%
FCF CAGR 10Y -92.4%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 5
EPS Growth Next 3Y 34.5%
Revenue Growth Next 3Y 474.5%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $180
Price Target Upside 17721.8%
Cash Flow
Operating Cash Flow $-27.1M
Free Cash Flow $-27.47M
Adj. Free Cash Flow $-28.7M
FCF Per Share -$6.37
OCF Per Share -$6.29
OCF/S Ratio -3757.1%
Income Statement
Revenue $721.39K
Gross Profit $58.19K
Operating Income $-30.08M
EBITDA $-47.68M
Net Income $-47.06M
EPS (Diluted) -$26.72
Revenue / Employee $6.27K
Profit / Employee $-409.19K
Employees 115
Add to Watchlist
Select watchlists to add or remove CODX